When considering the 97.5th percentile indicated by each specific assay manufacturer, 84.4%, 74.5%, and 73.3% of women with PCOS in our cohort showed AMH levels lower than such limits for the Gen II, picoAMH, and Elecsys assays, respectively. The gene discussed is AMH; the disease is polycystic ovary syndrome.